Published in Kidney Int on March 07, 2007
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol (2009) 1.86
Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care (2009) 1.75
Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol (2010) 1.75
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids Health Dis (2016) 1.44
Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol (2010) 1.31
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study. BMC Nephrol (2013) 1.10
Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol (2010) 1.08
Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care (2012) 1.06
The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study. J Am Coll Cardiol (2012) 1.06
The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol (2011) 1.05
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol (2011) 1.01
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol (2007) 0.98
Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol (2013) 0.98
Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Ther Adv Cardiovasc Dis (2013) 0.96
Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clin J Am Soc Nephrol (2011) 0.91
Type of arteriovenous vascular access and association with patency and mortality. BMC Nephrol (2013) 0.91
Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. Am J Cardiol (2008) 0.89
Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy. Cardiovasc Diabetol (2010) 0.88
Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol (2014) 0.85
Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease. Kidney Int (2007) 0.82
The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study. BMC Nephrol (2014) 0.82
Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol (2012) 0.81
Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One (2012) 0.80
Plasma levels of fetuin-A and risk of coronary heart disease in US women: the Nurses' Health Study. J Am Heart Assoc (2014) 0.80
Vascular and valvular calcification in chronic peritoneal dialysis patients. Int J Nephrol (2011) 0.79
Variability of laboratory parameters is associated with frailty markers and predicts non-cardiac mortality in hemodialysis patients. Clin Exp Nephrol (2015) 0.79
The role of fetuin-A in mineral trafficking and deposition. Bonekey Rep (2015) 0.78
Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression. PLoS One (2014) 0.78
Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis. PLoS One (2016) 0.78
Fetuin-A as a risk factor for mortality in hemodialysis patients. Wien Klin Wochenschr (2010) 0.77
Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch (2009) 0.76
Matrix γ-carboxyglutamate protein and Fetuin-A, in wet type age-related macular degeneration. Int J Ophthalmol (2015) 0.76
Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients. PLoS One (2016) 0.75
Hyperphosphatemia. The hidden killer in chronic kidney disease. Saudi Med J (2015) 0.75
Reappraisal of effects of serum chemerin and adiponectin levels and nutritional status on cardiovascular outcomes in prevalent hemodialysis patients. Sci Rep (2016) 0.75
The Clinical Role of CT-Based Morphologic Description in Severely Calcified Coronary Arteries Ectasia Encountering Acute Coronary Syndrome. Case Rep Cardiol (2012) 0.75
Fetuin-A and vascular calcification in Indian end-stage renal disease population. Indian J Nephrol (2016) 0.75
Urine and serum fetuin-A levels in patients with urolithiasis. Indian J Urol (2017) 0.75
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res (2003) 3.71
Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart (1999) 2.40
Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis (1997) 2.37
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost (2012) 2.17
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts. Eur J Vasc Endovasc Surg (2012) 2.01
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
[Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd (2008) 1.94
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant (2001) 1.87
Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res (2002) 1.79
Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest (1995) 1.79
Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int (2006) 1.74
Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med (1999) 1.71
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant (2007) 1.63
Upper extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg (2004) 1.57
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) (1989) 1.53
Measurement of hemodialysis vascular access flow using extracorporeal temperature gradients. Kidney Int (2007) 1.49
The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int (1994) 1.48
When to initiate dialysis: effect of proposed US guidelines on survival. Lancet (2001) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
Posttransplantation weight gain is predominantly due to an increase in body fat mass. Transplantation (2000) 1.44
[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?]. Dtsch Med Wochenschr (2007) 1.43
The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol (2003) 1.42
Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. Nephrol Dial Transplant (1996) 1.41
[Epoetin-induced pure red-cell aplasia]. Ned Tijdschr Geneeskd (2004) 1.41
Salt and hypertension in end-stage renal disease. Blood Purif (1998) 1.40
Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int (1990) 1.40
Predialytic period and baseline peritoneal membrane status: any connection? Perit Dial Int (2010) 1.39
Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int (1998) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol (1998) 1.38
Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int (1997) 1.37
Confounding: what it is and how to deal with it. Kidney Int (2007) 1.37
Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest (1990) 1.36
Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int (1992) 1.34
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid (1997) 1.31
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) (2001) 1.30
Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med (2011) 1.28
Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1996) 1.25
Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol (1997) 1.25
Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant (1990) 1.23
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr (2004) 1.23
Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.22
Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.20
Undertreatment of asthma in Dutch general practice. Fam Pract (1987) 1.16
Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis (2000) 1.13
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant (1994) 1.13
Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial (1999) 1.12
A circadian rhythm of proteinuria in patients with a nephrotic syndrome. Clin Sci (Lond) (1985) 1.11
beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl (2001) 1.10
The valuable contribution of observational studies to nephrology. Kidney Int (2007) 1.10
Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int (1997) 1.09
Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med (1997) 1.09
Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. Neth J Med (1994) 1.08
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int (2001) 1.07
Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J Natl Cancer Inst (1994) 1.07
Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol (1993) 1.07
Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol (1997) 1.06
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int (1994) 1.06
Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant (2001) 1.06
Bias in clinical research. Kidney Int (2007) 1.05
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia (2013) 1.04
Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int (1996) 1.04
Changes in employment status in end-stage renal disease patients during their first year of dialysis. Perit Dial Int (2002) 1.03
The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int (1995) 1.03
Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.03
Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol (1998) 1.03
Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis (1993) 1.02
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int (2006) 1.02